A Study on Safety and Immune Response of Investigational RSV OA Vaccine in Combination With Herpes Zoster Vaccine in Healthy Adults

Clinical trial NCT05966090 · COMPLETED

Trial details

NCT number: NCT05966090
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Respiratory Syncytial Viruses Respiratory Syncytial Virus Infections

Start date: 2023-07-28
Primary completion: 2024-02-19
Enrollment: 530

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.